Sign in
Author
|
Conference
|
Journal
|
Organization
|
Year
|
DOI
Look for results that meet for the following criteria:
since
equal to
before
between
and
Search in all fields of study
Limit my searches in the following fields of study
Agriculture Science
Arts & Humanities
Biology
Chemistry
Computer Science
Economics & Business
Engineering
Environmental Sciences
Geosciences
Material Science
Mathematics
Medicine
Physics
Social Science
Multidisciplinary
Co-authors
(979)
Morie A. Gertz
172
S. Vincent Rajkumar
160
Philip R. Greipp
126
Angela Dispenzieri
126
Martha Q. Lacy
102
Journals
(102)
JAMA-J AM MED ASSN
152
MAYO CLIN PROC
72
Leukemia
33
BRIT J HAEMATOL
26
AMER J HEMATOL
25
Keywords
(469)
Embed
Subscribe
Academic
Authors
Robert A. Kyle
Robert A. Kyle,Mayo Clinic,Oncology,Cardiology,Pharmacology
Edit
Robert A. Kyle
Mayo Clinic
Publications:
676
|
Citations:
10610
Fields:
Oncology
,
Cardiology
,
Pharmacology
View FAQ about top research areas and Fields of study
Collaborated with
979 co-authors
from 1966 to 2012
|
Cited by
19102 authors
Cumulative
Annual
Sort by:
Publications
(676)
BibTeX
|
RIS
|
RefWorks
Download
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study
S K Kumar
,
J H Lee
,
J J Lahuerta
,
G Morgan
,
P G Richardson
,
J Crowley
,
J Haessler
,
J Feather
,
A Hoering
,
P Moreau
,
X LeLeu
,
C Hulin
Robert A Kyle
http://academic.research.microsoft.com/io.ashx?type=5&id=56564055&selfId1=23439991&selfId2=0&maxNumber=12&query=
Journal:
Leukemia
, vol. 26, no. 1, pp. 149-157, 2012
Long-Term Follow-Up of Patients with Monoclonal Gammopathy of Undetermined Significance after Kidney Transplantation
Harris V. K. Naina
,
Samar Harris
,
Angela Dispenzieri
,
Fernando G. Cosio
,
Thomas M. Habermann
,
Mark D. Stegall
,
Patrick G. Dean
,
Mikel Prieto
,
Robert A. Kyle
,
S. Vincent Rajkumar
,
Nelson Leung
Journal:
American Journal of Nephrology - AMER J NEPHROL
, vol. 35, pp. 365-371, 2012
Novel approaches for reducing free light chains in patients with myeloma kidney
Joan Bladé
,
Paul Cockwell
,
Mark Cook
,
Mark Drayson
,
Jean-Paul Fermand
,
Efstathios Kastritis
,
Robert Kyle
,
Nelson Leung
,
Sonia Pasquali
,
Christopher Winearls
,
Colin A. Hutchison
Journal:
Nature Reviews Nephrology - NAT REV NEPHROL
, vol. 8, no. 4, pp. 234-243, 2012
Polymorphism of the erythropoietin gene promotor and the development of myelodysplastic syndromes subsequent to multiple myeloma
O Landgren
,
W Ma
,
R A Kyle
,
S V Rajkumar
,
N Korde
,
M Albitar
Journal:
Leukemia
, vol. 26, no. 4, pp. 844-845, 2012
Asymptomatic immunoglobulin light chain amyloidosis (AL) at the time of diagnostic bone marrow biopsy in newly diagnosed patients with multiple myeloma and smoldering myeloma. A series of 144 cases and a review of the literature
(
Citations: 1
)
Sergio Siragusa
,
William Morice
,
Morie A. Gertz
,
Robert A. Kyle
,
Philip R. Greipp
,
John A. Lust
,
Thomas E. Witzig
,
Martha Q. Lacy
,
Steven R. Zeldenrust
,
S. Vincent Rajkumar
,
Stephen J. Russell
,
Suzanne R. Hayman
http://academic.research.microsoft.com/io.ashx?type=5&id=31275702&selfId1=23439991&selfId2=0&maxNumber=12&query=
Journal:
Annals of Hematology - ANN HEMATOL
, vol. 90, no. 1, pp. 101-106, 2011
Sort by:
Citations
(10610 times by 5530 publications)
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study
S K Kumar
,
J H Lee
,
J J Lahuerta
,
G Morgan
,
P G Richardson
,
J Crowley
,
J Haessler
,
J Feather
,
A Hoering
,
P Moreau
,
X LeLeu
,
C Hulin
Robert A Kyle
http://academic.research.microsoft.com/io.ashx?type=5&id=56564055&selfId1=23439991&selfId2=0&maxNumber=12&query=
Journal:
Leukemia
, vol. 26, no. 1, pp. 149-157, 2012
Management of treatment-emergent peripheral neuropathy in multiple myeloma
P G Richardson
,
M Delforge
,
M Beksac
,
P Wen
,
J L Jongen
,
O Sezer
,
E Terpos
,
N Munshi
,
A Palumbo
,
S V Rajkumar
,
J L Harousseau
,
P Moreau
http://academic.research.microsoft.com/io.ashx?type=5&id=56564173&selfId1=23439991&selfId2=0&maxNumber=12&query=
Journal:
Leukemia
, vol. 26, no. 4, pp. 595-608, 2012
A novel prognostic model in myeloma based on co-segregating adverse FISH lesions and the ISS: analysis of patients treated in the MRC Myeloma IX trial
K D Boyd
,
F M Ross
,
L Chiecchio
,
G P Dagrada
,
Z J Konn
,
W J Tapper
,
B A Walker
,
C P Wardell
,
W M Gregory
,
A J Szubert
,
S E Bell
,
J A Child
http://academic.research.microsoft.com/io.ashx?type=5&id=56564065&selfId1=23439991&selfId2=0&maxNumber=12&query=
Journal:
Leukemia
, vol. 26, no. 2, pp. 349-355, 2012
Cytogenetic and therapeutic characterization of primary plasma cell leukemia: the IFM experience
H Avet-Loiseau
,
M Roussel
,
L Campion
,
X Leleu
,
G Marit
,
H Jardel
,
M Dib
,
O Decaux
,
T Lamy
,
M Tiab
,
P Cony-Makhoul
,
A Banos
http://academic.research.microsoft.com/io.ashx?type=5&id=56564033&selfId1=23439991&selfId2=0&maxNumber=12&query=
Journal:
Leukemia
, vol. 26, no. 1, pp. 158-159, 2012
Proposed definition of ‘poor mobilizer’ in lymphoma and multiple myeloma: an analytic hierarchy process by ad hoc working group Gruppo ItalianoTrapianto di Midollo Osseo
A Olivieri
,
M Marchetti
,
R Lemoli
,
C Tarella
,
A Iacone
,
F Lanza
,
A Rambaldi
,
A Bosi
Journal:
Bone Marrow Transplantation - BONE MARROW TRANSPLANT
, vol. 47, no. 3, pp. 342-351, 2012
Comments